Selective mitochondrial glutathione depletion by ethanol enhances acetaminophen toxicity in rat liver

Hepatology

Volumn 36, Issue 2, 2002, Pages 326-335

  Zhao, Ping ^a   Kalhorn, Thomas F ^a   Slattery, John T ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CYTOCHROME P450 2E1; DIETHYLTHIOCARBAMATE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; MALEIC ACID DIETHYL ESTER; N ACETYL 1,4 BENZOQUINONE IMINE; PARACETAMOL; SUCCINATE DEHYDROGENASE;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; DRUG TOXICITY; ENZYME INACTIVATION; ENZYME INDUCTION; LIVER MITOCHONDRION; LIVER TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0036322172     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.34943     Document Type: Article

References (44)

1. A comprehensive ongoing population-based survey of medication use in the United States - The adult population
2. Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure
3. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: Analysis of instances of therapeutic misadventure
4. Treatment of pain or fever with paracetamol (acetaminophen) in the alcoholic patient: A systematic review
5. Therapeutic misadventure with paracetamol: Fact or fiction?
6. Effect of maximal daily doses of acetaminophen on the liver of alcoholic patients: A randomized, double-blind, placebo-controlled trial
7. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism
8. Molecular mechanisms of the hepatotoxicity caused by acetaminophen
9. Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation
10. Increased hepatotoxicity of acetaminophen after chronic ethanol consumption in the rat
11. Pharmacokinetic consequences of induction of CYP2E1 by ligand stabilization
12. Ethanol induces CYP2E1 by protein stabilization. Role of ubiquitin conjugation in the rapid degradation of CYP2E1
13. Cytochrome P450 CYP 2E1 induction during chronic alcohol exposure occurs by a two-step mechanism associated with blood alcohol concentrations in rats
14. Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA
15. Mechanism of the preventive effect of ethanol on acetaminophen-induced hepatoxicity
16. Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults
17. Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics
18. Hepatic mitochondrial glutathione depletion and progression of experimental alcoholic liver disease in rats
19. Transport of reduced glutathione in hepatic mitochondria and mitoplasts from ethanol-treated rats: Effect of membrane physical properties and S-adenosyl-L-methionine
20. Tauroursodeoxycholic acid protects hepatocytes from ethanol-fed rats against tumor necrosis factor-induced cell death by replenishing mitochondrial glutathione
21. Acetaminophen toxicity results in site-specific mitochondrial damage in isolated mouse hepatocytes
22. Effect of acetaminophen administration on hepatic glutathione compartmentation and mitochondrial energy metabolism in the rat
23. Subcellular binding and effects on calcium homeostasis produced by acetaminophen and a nonhepatotoxic regioisomer, 3′-hydroxyacetanilide, in mouse liver
24. Synthesis, decomposition kinetics, and preliminary toxicological studies of pure N-acetyl-p-benzoquinone imine, a proposed toxic metabolite of acetaminophen
25. Experimental methods of ethanol administration
26. Organ slices as an in vitro test system for drug metabolism in human liver, lung and kidney
27. Biotransformation of chlorzoxazone by hepatic microsomes from humans and ten other mammalian species
28. Oxidation of acetaminophen to its toxic quinone imine and nontoxic catechol metabolites by baculovirus-expressed and purified human cytochromes P450 2E1 and 2A6
29. Single-dose disulfiram inhibition of chlorzoxazone metabolism: A clinical probe for P450 2E1
30. Duration of cytochrome P-450 2E1 (CYP2E1) inhibition and estimation of functional CYP2E1 enzyme half-life after single-dose disulfiram administration in humans
31. Estimation of biomass in growing cell lines by adenosine triphosphate assay
32. Use of human organ slices to evaluate the biotransformation and drug-induced side-effects of pharmaceuticals
33. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation
34. Isolation of mitochondria, mitochondrial membranes, lysosomes, peroxisomes, and Golgi membranes from rat liver
35. Citrate Synthase
36. Preparation and properties of succinate: Ubiquinone oxidoreductase (complex II)
37. Determination of reduced, oxidized, and protein-bound glutathione in human plasma with precolumn derivatization with monobromobimane and liquid chromatography
38. Acetaminophen-induced hepatotoxicity. Analysis of total covalent binding vs. specific binding to cysteine
39. GSH transport in mitochondria: Defense against TNF-induced oxidative stress and alcohol-induced defect
40. N-acetyl-p-benzoquinone imine: A cytochrome P-450-mediated oxidation product of acetaminophen
41. Ethanol metabolism, cirrhosis and alcoholism
42. Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat
43. Development of a new, simple rat model of early alcohol-induced liver injury based on sensitization of Kupffer cells
44. Protection against acetaminophen-induced liver injury and lethality by interleukin 10: Role of inducible nitric oxide synthase